Carsten Boess

Carsten Boess discloses dealings in 2 companies, chiefly Avidity Biosciences, Inc. and Rocket Pharmaceuticals, Inc. In total, 4 filings cover trades dated from 10 June 2025 to 18 June 2026.

The filings describe grants, exercises and other transfers rather than trades on the open market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.

The latest filing, published on 6 July 2026, reports a share grant in Rocket Pharmaceuticals, Inc. Filings reach the SEC (Form 4) feed a median of 18 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.